Crossmark

Intranasal esketamine for treatment-resistant depression: real-world effectiveness in electroconvulsive therapy non-responders

Crossref DOI link: https://doi.org/10.1016/j.ejpsy.2026.100349

Published Print: 2026-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gómez-Juanes, Rocío https://orcid.org/0000-0002-9040-5508
Lázaro, Guillermo Mompaler

Castro, Adoración https://orcid.org/0000-0002-8025-4945
Navarra-Ventura, Guillem https://orcid.org/0000-0001-9839-7357
Quetglas, Josep Antoni Mestre

Marset, Ana Bolon

Monasterio, Julia Van der Walt

Trullols, Jaume Andreu Garcias

Roca, Miquel

Gili, Margalida

Salvà, Joan

Garcia-Toro, Mauro https://orcid.org/0000-0002-2251-1368
License Information

Text and Data Mining valid from 2026-04-01

Text and Data Mining valid from 2026-04-01

Version of Record valid from 2026-02-23
More Information

This article is maintained by: Elsevier

Article Title: Intranasal esketamine for treatment-resistant depression: real-world effectiveness in electroconvulsive therapy non-responders

Journal Title: The European Journal of Psychiatry

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ejpsy.2026.100349

Content Type: article

Copyright: © 2026 The Authors. Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Psiquiatría y Salud Mental.